Phibro Animal Health Corp. (PAHC) Social Stream
PHIBRO ANIMAL HEALTH CORP (PAHC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PAHC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 2 | $23 | $17 | $20 | $15.03 | 33.07% |
| 2021-11-18 | 3 | $23 | $17 | $21 | $15.03 | 39.72% |
| 2022-02-11 | 3 | $23 | $17 | $21 | $15.03 | 39.72% |
| 2022-05-06 | 3 | $23 | $18 | $21.333 | $15.03 | 41.94% |
| 2022-08-13 | 3 | $23 | $18 | $21 | $15.03 | 39.72% |
| 2022-09-10 | 3 | $22 | $16 | $19.666 | $15.03 | 30.84% |
| 2022-09-17 | 3 | $21 | $16 | $18 | $15.03 | 19.76% |
| 2022-10-26 | 3 | $21 | $14 | $17.333 | $15.03 | 15.32% |
| 2022-11-09 | 3 | $20 | $14 | $17 | $15.03 | 13.11% |
| 2022-11-17 | 4 | $20 | $12 | $16.333 | $15.03 | 8.67% |
| 2023-02-08 | 4 | $20 | $12 | $16.75 | $15.03 | 11.44% |
| 2023-02-09 | 4 | $21 | $12 | $17.25 | $15.03 | 14.77% |
The Trend in the Analyst Price Target
Over the past 18 months, PAHC's average price target has gone down $4.42.
Over the past 40 weeks, PAHC's average upside potential has been 17.38%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-06 | 3 | 23 | 18 | 21.333 | 18.73 | 13.9% |
| 2022-10-26 | 3 | 21 | 14 | 17.333 | 14.49 | 19.62% |
| 2022-12-21 | 4 | 20 | 12 | 16.750 | 13.67 | 22.53% |
| 2023-01-27 | 4 | 20 | 12 | 16.750 | 15.25 | 9.84% |
| 2023-02-08 | 4 | 20 | 12 | 16.750 | 15.90 | 5.35% |
PAHC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.25 | 1 | 0 | 1 | 1 | 1 | 4 |
The Trend in the Broker Recommendations
PAHC's average broker recommendation rating improved by 0.42 over the prior 16 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- PAHC has a higher number of analysts covering the stock than 118.61% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PHIBRO ANIMAL HEALTH CORP's upside potential (average analyst target price relative to current price) is higher than 194.09% of them.
- In terms of how PHIBRO ANIMAL HEALTH CORP fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -176.72% of that group.
- In the context of stocks in the mid market cap category, PHIBRO ANIMAL HEALTH CORP's average analyst price target is higher than 289.15% of them.
Stocks similar to PHIBRO ANIMAL HEALTH CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RVNC, SAGE, and RCKT.
View All Top Stocks by Price Target
Make investment decisions regarding PAHC using the data that counts. Try POWR Ratings for free.